Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Open Orphan Plc LSE:ORPH London Ordinary Share GB00B9275X97 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.50 2.08% 24.50 24.00 25.00 24.75 23.75 24.00 2,577,686 09:34:57
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 3.3 -5.6 -3.4 - 164

Open Orphan Share Discussion Threads

Showing 9751 to 9775 of 12200 messages
Chat Pages: Latest  392  391  390  389  388  387  386  385  384  383  382  381  Older
DateSubjectAuthorDiscuss
19/11/2020
21:55
I do not see him as the evangelical company leader in spite of his rhetoric. They are two a penny on AIM. I see him as a hard-nosed businessman with a firm focus on building the share price and delivering deals with a sharp eye on costs and margins. Very comfortable with my investment here.
inaminute
19/11/2020
21:54
On 6th November Adrian Wildfire of Chimagents was made a director of Prep Biopharm. That's one way of rewarding him for his loyalty to Orph.
gregb
19/11/2020
21:00
He didn't like the suggestion he's not delivering did he! Only moving house, quadruped the sp, negotiating multi multi million pound deals with smart device manufactures, dealing with 40m government contracts, stolen a ready to go team from SGS just as challenge studies are becoming the focus of the vaccine world, got into a position to be paid for advising the world of challenge studies.. to name a few bits in the last few months. Give him a break
lukehold
19/11/2020
20:52
Good feedback and commentary chaps. The presentation was great viewing and makes for a comfortable hold for me personally. Ok some timeline slippage, but direction is most definitely onwards and upwards.
uapatel
19/11/2020
20:44
Great to see so many positive posts after tonights presentation. I think all LTH’s understand and appreciate the vast potential in ORPH and the Herculean effort Cathal is making to progress everything. The highlight for me (apart from a possible large lucrative China deal!) was SGS more or less being confirmed as the third facility and ‘sharing revenues’ with ORPH (I’m also quite relieved that no imminent buy out appears to be on the cards, but I agree that SGS may make this move at a future date). SGS’s new 45 bed facilty in mid 2021 can potentially double ORPH’s revenues yet again (in addition to the Royal Free Hospital beds) and secure further recurring revenues in future years (hopefully we’ll get a more accurate broker update soon, taking these factors into account). Cathal moving to London with his family, reinforces his commitment to the business and no doubt will drive further expansion, which is set to grow significantly in the short to medium term. IMHO GLA
trader_3
19/11/2020
20:17
I would like to see the price going up of course, but I have to find a way of realising some more money, so I can add. To bring his family over is a real commitment to the business, but its what you expect from CF.I know we keep saying it but its a bloody exciting Company to be involved with truly huge prospects. That Chinese mention was very interesting, that certainly could be a biggi.
m5
19/11/2020
19:50
I thought Cathal was excellent tonight and although calm he was really bullish about where we are heading. I just wonder if it had been mentioned this morning that there was monthly revenue from the Wellcome Trust collaboration whether we would have ended today in the red? I’m pretty confident that tomorrow will be a blue day. Now in talks with the Chinese. You can’t accuse Cathal of putting his feet up!
chelsea101
19/11/2020
19:31
Plasybryn clearly some large divis are going to happen :0)
pogue
19/11/2020
19:26
Yes he was calmer and spoke better. More considered and mature. Brought to task about over promising which hopefully will make him think. Sarah reminded him shareholders remember what has been said/promised. I think he needs to cut back on so many presentations and use them to really drive home significant achievements. The slides & the speech could be cut back and focused on what we want to hear. That is commitment for the family to move to London. He will have to prove to them it was worth it! They are more demanding than us the Orphan Army I suspect.
plasybryn
19/11/2020
19:25
8464, 1g There's 30m of gov work in royal free - I expect that will take up much of next year. Th covid studies are bigger than others, and add in the facility if being provided for free, and 19 beds v 24 beds, then it seems consistent with the qm facility maxing out at 60m. Probably 20m profit from qm, and 20m from royal free (due to much less costs). So i'd say no rns because the revenue from it for next year is covered in the gov contract rns. C did imply we've got royal free for 18m (or did i mishear?), so probably 6 months for non gov work. If those figures are ballpark, just the challenge study work gives 40m profit next year. Let's divide by 2 in case it's too generous. What cap should orph be if earnings next year are £20m (just from this one area). ppe 20 gives 400m, ppe 30 gives 600m. (just from qm and rf, ignoring everything else).
pierre oreilly
19/11/2020
19:21
Tonight was the first time that I have listened to CF.I could hear him clearly. He spoke slowly,was impressive. His vision,intentions regarding prioritising the running of the Company going forward gave me total confidence. CF has won me over and I will continue to build my position.
klosters65
19/11/2020
19:19
Much better presentation tonight . Rey positive
talkman2
19/11/2020
19:12
Why have we not had an RNS to say that Orph has secured access to the Royal Free beyond the 3 government-sponsored studies? Surely that is material.
1gw
19/11/2020
19:11
Looks to me like the wearables deal is imminent, before Christmas? Speaking to 10 wearables and tech Companies. Moving to London must make sense for him and his family. SGS might not be buying us anytime soon,that suits me, but I think that's where we will end up. Good presentation. He got a bit of stick but dealt with it well. All good.
m5
19/11/2020
19:10
Sounds like the Imutex deal delay is a bit less certain now. He is talking about end-of-the-year/early next year and pointing out that there are still 6 weeks left in the year. So it might slip until February or so (3 months indication given in previous presentation) but could still do it closer to the earlier Christmas guidance. Which must mean there are some fairly active negotiations underway I would have thought.
1gw
19/11/2020
19:09
I used to work for Parity in the early 90s, made a fair bit on their share employee scheme.
realcooltrader
19/11/2020
19:07
Oooh Parity, made more on that than any other share, easy in the tech boom days.
pierre oreilly
19/11/2020
19:07
She's got a real soft spot for our Cathal! I'm really glad I have a large % of my portfolio here, the use of the word exponential is very pleasing.
realcooltrader
19/11/2020
19:06
Well the take over is off I would say, he is moving the family to London, looks like the long haul and divis!
pogue
19/11/2020
18:56
Institutions been loading up their stocks last few weeks pushing out the panic and impatient sellers ahead of the next steady rise up. Just what CF wants! I’m sure the immutex delay last Friday could easily of been a ploy to feed the institutions further this week. Just made it clear in today’s presentation that it is due to prioritising the wearables deals and pulling off multiple multimillion pound deals stretches you. Could of easily said that last Friday which I’m sure institutions already knew about.
1trickydicky
19/11/2020
18:33
Cheers. On now.
m5
19/11/2020
18:31
Sensyne seems like vapourware to me. An idea to develop some software. All frills and no knickers. Typical aim company to avoid imv. Good luck to investors there. Won't be around in another 2 years. And that is capped more than orph? wtf?
pierre oreilly
19/11/2020
18:31
https://www.youtube.com/watch?v=ll7tWyxcOpQ
toyin
19/11/2020
18:28
Sorry anyone got a link?
lukehold
19/11/2020
18:08
m5, he's on second, after Sensyne who is presenting right now. "Sarah Lowther The order is Sensyne, Orphan and Parity. All cracking companies"
realcooltrader
Chat Pages: Latest  392  391  390  389  388  387  386  385  384  383  382  381  Older
ADVFN Advertorial
Your Recent History
LSE
ORPH
Open Orpha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210123 15:29:17